Literature DB >> 15814967

European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index.

Eskild Petersen1, Maria Victoria Borobio, Edward Guy, Oliver Liesenfeld, Valeria Meroni, Anne Naessens, Emma Spranzi, Philippe Thulliez.   

Abstract

The LIAISON system is a fully automated system based on chemiluminescence and antigen bound to magnetic microparticles. The system allows fast and precise measurement of Toxoplasma-specific immunoglobulin G (IgG) and IgM antibody levels and measurement of the IgG avidity index even at low levels of Toxoplasma-specific IgG antibodies in a single step without manual interference. Seven European centers participated in a multicenter evaluation of the LIAISON system. The sensitivity and specificity of the LIAISON system compared to the Sabin-Feldman dye test were 99.3 and 96.8%, respectively. In a comparison of the LIAISON Toxoplasma-specific IgM assay with an immunosorbent agglutination assay, the LIAISON assay had a sensitivity of 96.7% and a specificity of 95.4%. The LIAISON IgG assay showed agreements of 91, 100, and 100% with the AXSYM IgG (Abbott), VIDAS IgG (bioMerieux), and Platelia IgG (Bio-Rad) assays, respectively. The LIAISON IgM assay showed agreements of 95% with the AXSYM IgM and Platelia IgM assays, 96% with the ISAGA IgM assay (bioMerieux), and 97% with the VIDAS IgM assay. The coefficient of correlation between the LIAISON system and the VIDAS Toxoplasma-specific IgG avidity index was 0.81. By use of the Toxoplasma-specific IgG avidity index assay with specific IgM-positive samples, the diagnosis of infection with Toxoplasma gondii in early pregnancy has been improved significantly. The LIAISON avidity assay is a valuable assay for the exclusion of recently acquired infection with T. gondii (less than 4 months) in pregnant women, and it decreases significantly the necessity for follow-up testing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814967      PMCID: PMC1081322          DOI: 10.1128/JCM.43.4.1570-1574.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  A new method with general diagnostic utility for the calculation of immunoglobulin G avidity.

Authors:  M H Korhonen; J Brunstein; H Haario; A Katnikov; R Rescaldani; K Hedman
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis.

Authors:  I Reiter-Owona; E Petersen; D Joynson; H Aspöck; M L Dardé; R Disko; O Dreazen; H Dumon; R Grillo; U Gross; M Hayde; R Holliman; D O Ho-Yen; K Janitschke; P A Jenum; K Naser; M Olszewski; P Thulliez; H M Seitz
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

3.  Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems.

Authors:  R J Diepersloot; H Dunnewold-Hoekstra; J Kruit-Den Hollander; F Vlaspolder
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

4.  Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii.

Authors:  A Roberts; K Hedman; V Luyasu; J Zufferey; M H Bessières; R M Blatz; E Candolfi; A Decoster; G Enders; U Gross; E Guy; M Hayde; D Ho-Yen; J Johnson; B Lécolier; A Naessens; H Pelloux; P Thulliez; E Petersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-07       Impact factor: 3.267

5.  Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy.

Authors:  A E Ades
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

6.  Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux).

Authors:  H Pelloux; E Brun; G Vernet; S Marcillat; M Jolivet; D Guergour; H Fricker-Hidalgo; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  Diagn Microbiol Infect Dis       Date:  1998-10       Impact factor: 2.803

7.  Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii.

Authors:  B R Dannemann; W C Vaughan; P Thulliez; J S Remington
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

8.  IgG recognizing 21-24 kDa and 30-33 kDa tachyzoite antigens show maximum avidity maturation during natural and accidental human toxoplasmosis.

Authors:  M Villavedra; J Battistoni; A Nieto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1999 Sep-Oct       Impact factor: 1.846

9.  The diagnosis of toxoplasmosis using IgG avidity.

Authors:  R E Holliman; R Raymond; N Renton; J D Johnson
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

10.  Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies.

Authors:  L Gras; R E Gilbert; M Wallon; F Peyron; M Cortina-Borja
Journal:  Epidemiol Infect       Date:  2004-06       Impact factor: 2.451

View more
  39 in total

1.  Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women.

Authors:  M Lefevre-Pettazzoni; A Bissery; M Wallon; G Cozon; F Peyron; M Rabilloud
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

2.  Prevention of assay interference in infectious-disease serology tests done on the liaison platform.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

3.  Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot.

Authors:  Arnaud Maudry; Gautier Chene; Rémi Chatelain; Hugues Patural; Bahrie Bellete; Bernard Tisseur; Jamal Hafid; Hélène Raberin; Sophie Beretta; Roger Tran Manh Sung; Georges Belot; Pierre Flori
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

4.  Evaluation of Toxoplasma gondii immunoglobulin G (IgG) and IgM assays incorporating the newVidia analyzer system.

Authors:  Adriana Calderaro; Giovanna Piccolo; Simona Peruzzi; Chiara Gorrini; Carlo Chezzi; Giuseppe Dettori
Journal:  Clin Vaccine Immunol       Date:  2008-05-14

5.  Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Barbara Francis; Nicholas Laven; Joan Marler; David Dickeson; Tony Panayotou; Kim Wilson; Robyn Wootten; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

6.  Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis.

Authors:  O Villard; B Cimon; C L'Ollivier; H Fricker-Hidalgo; N Godineau; S Houze; L Paris; H Pelloux; I Villena; E Candolfi
Journal:  J Clin Microbiol       Date:  2016-10-12       Impact factor: 5.948

7.  Identification of Toxoplasma gondii antigens associated with different types of infection by serum antibody profiling.

Authors:  Jiin Felgner; Silvia Juarez; Chris Hung; L I Liang; Aarti Jain; Mert Döşkaya; Philip L Felgner; Ayşe Caner; Yüksel Gürüz; D Huw Davies
Journal:  Parasitology       Date:  2015-01-14       Impact factor: 3.234

8.  Detection of toxoplasma-specific immunoglobulin G in human sera: performance comparison of in house Dot-ELISA with ECLIA and ELISA.

Authors:  Aref Teimouri; Mohammad Hossein Modarressi; Saeedeh Shojaee; Mehdi Mohebali; Nima Zouei; Mostafa Rezaian; Hossein Keshavarz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-08       Impact factor: 3.267

9.  Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women.

Authors:  David C Kasper; Andrea R Prusa; Michael Hayde; Nicole Gerstl; Arnold Pollak; Kurt R Herkner; Rosmarie Reiter-Reisacher
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

10.  Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies.

Authors:  V Meroni; F Genco; C Tinelli; P Lanzarini; L Bollani; M Stronati; E Petersen
Journal:  Clin Vaccine Immunol       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.